10:03 AM EDT, 08/08/2024 (MT Newswires) -- Novavax ( NVAX ) shares were falling 3.3% in recent Thursday trading after the company's Q2 earnings and revenue missed analysts' estimates.

The company reported Q2 earnings Thursday of $0.99 per diluted share, up from $0.58 a year earlier.

Four analysts polled by Capital IQ expected $1.67.

Revenue for the quarter ended June 30 was $415.5 million, down from $424.4 million a year earlier.

Four analysts surveyed by Capital IQ expected $428.5 million.

The company said it now expects 2024 revenue between $700 million and $800 million. The previous guidance was for revenue between $400 million and $600 million.

Analysts polled by Capital IQ expect $937.2 million.

Price: 10.36, Change: -0.35, Percent Change: -3.27